RX 526: Federal Laws Intro

0.0(0)
studied byStudied by 0 people
0.0(0)
call with kaiCall with Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/45

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 2:23 AM on 1/31/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

46 Terms

1
New cards

FD & C Landmark Laws

- Pure Food and Drug Act of 1906

- Food, Drug, and Cosmetic Act (FDCA) of 1938

- Durham-Humphrey Amendment of 1951

- Kefauver-Harris Amendment of 1962

- Medical Device Amendments of 1976

2
New cards

Pure Food and Drug Act of 1906

- Prohibited adulteration and misbranding of foods and drugs in interstate commerce

--- DID NOT include that misbranding includes false or misleading efficacy claims

- This led to Pure Food and Drug Act of 1912

--- Required the government to prove fraudulent intent

3
New cards

Food, Drug, and Cosmetic Act (FDCA) of 1938

- No new drug could be marketed until proven safe for use described on the label and approved by the FD

- Expanded definitions of adulteration and misbranding

- Labels must include "adequate directions for use" and warnings about habit-forming potential of certain medications

- Exempted drugs marketed before 1938 to be proven safe

- Added cosmetics and devices

4
New cards

Durham-Humphrey Amendment of 1951

- Created prescription and over the counter classes*

- "Caution: Federal law prohibits dispensing without a prescription"

--- Pharmacist placing label of directions on prescription satisfies "adequate directions for use"

- Authorized oral prescriptions and refills of prescription medications

5
New cards

Kefauver-Harris Amendment of 1962

- Drugs must be proven safe AND effective

- FDA given jurisdiction over prescription drug advertising

- Established Good Manufacturing Practices (GMP)

- Informed consent of research subjects and reporting of adverse drug reactions in clinical trials

6
New cards

Thalidomide led to what law/amendment?

Kefauver-Harris Amendment of 1962

7
New cards

Medical Device Amendments of 1976

- Classification of devices

- Premarket approval

- Performance standards

- GMP regulations

- Record and reporting requirements

8
New cards

Drug definition

1. "Articles recognized in the official compendium or any supplement of the official compendium."

2. AND intended for the use in diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animal

3. AND article (other than food) intended to affect the structure or any function of the body in man or other animal

4. AND articles intended for use as a component of any article specified in any of the above bullet points

9
New cards

Cosmetic definition

Articles intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applies to the human body or any part thereof for cleansing, beautifying, promoting attractiveness, or altering the appearance, AND articles intended for use as a component of any such articles

- Except that such term shall not include soap

10
New cards

Are Articles drugs or cosmetics?

Articles can be a drug AND a cosmetic (ex. Medicated shampoos)

11
New cards

Food

1. Articles used for food or drink for man or other animals

2. Chewing gum

3. Articles used for components of articles in 1 and 2

12
New cards

Prescription Drug Definition

- Rx-only or legend drug

- Supervision for safe and effective use

--- Supervision = practitioner

- Concerns with toxicity, potential for harmful effects, how it is administered/used, collateral measures for use

- "Unavoidably unsafe" but not "unreasonably dangerous"

13
New cards

Over-the-counter (OTC) definition

- Safe and effective for use without supervision

- OTC vs Rx status can vary by indication

14
New cards

Behind-the-counter definition

- Third, "unofficial" class

- Proposals or state-specific

- Example: PSE

15
New cards

Orphan Drug definition

- Drugs for Rare Diseases

- Used for a condition that:

--- Affects less than 200,000 people in the US OR

--- Affects more than 200,000 people but the cost of developing and making the drug will not be covered from sales

- If found to have another use, it does NOT lose orphan drug status

16
New cards

Dietary Supplement

Product (other than tobacco) intended to supplement the diet that contains one or more of the following:

--- Vitamin

--- Mineral

--- Herb or other botanical

--- Amino acid

--- Dietary substance for use by man to supplement the diet by increasing the total dietary intake OR

--- Concentrate, metabolite, constituent, extract, or combination of any ingredient described in clause A through E

17
New cards

Pre-1938 drugs definition

Assumed safe and effective due to length of use

18
New cards

DESI: drugs marketed from 1938-1962

Proven to be SAFE but NOT effective

19
New cards

DESI

drug efficacy study implementation

20
New cards

Post-1962 Drugs definition

- Subject to higher standards for safety AND effectiveness

- Must go through full FDA approval process, including INDA/NDA

21
New cards

Pre-'38 Drugs examples

- Thyroid hormone

- Morphine

- Codeine

- Nitroglycerin

22
New cards

DESI Drugs

- Drug Efficacy Study Implementation

- Drugs introduced between 1938-1962

--- Safe but NOT known to be effective

- Effectiveness had to be proven or removed from market

23
New cards

New Drug

- Not generally recognized as safe (GRAS) and not generally recognized as effective (GRAE)

--- GRASE (not generally recognized as safe and effective)

- New condition or new dosage form

- Must go through new drug application for FDA approval

24
New cards

Device definition

Instrument or related article that is:

1. Recognized in USP, NF, or any supplement AND

2. Intended for use in the diagnosis of disease or other condition, or in the cure, mitigation, treatment, or prevention of disease in man or other animal, AND

3. Intended to affect the structure or any function of the body in man or other animal, and which does not achieve its primary intended purposes through chemical action and which is not dependent upon being metabolized for the achievement of its intended purpose

25
New cards

Drug or Device?

- Is the product intended to deliver drugs to the patient, but is not prefilled by the manufacturer?

- Is the drug component included solely to make the product safer?

- Is the drug component intended to have a therapeutic effect?

26
New cards

Medical Devices: Classes

- Class I

- Class II

- Class III

27
New cards

Medical Devices: Device types

- Restricted

- Custom

- Banned

28
New cards

Class I Devices

- Least dangerous; "low risk"

- Do not support life, sustain life, or present an unreasonable risk of illness or injury with use

- Subject to "general controls"

--- Must conform with cGMP

29
New cards

Class I Devices examples

Stethoscope, scissors, toothbrushes, ventilator tubing

30
New cards

Class II Devices

- More "dangerous" than class I

--- Moderate risk

- Require special controls

--- Performance standards set by experts

--- Most likely to require premarket notification

31
New cards

Class II Devices examples

Syringes, tampons, condoms, HbA1c immunoassay

32
New cards

Class III Devices

- Most serious/"dangerous"

--- "High risk"

- Support life, sustain life, prevent the impairment of human health, or present unreasonable risk of illness or injury

- REQUIRE pre-market approval

--- Similar to new drug

33
New cards

Class III Devices examples

Pacemakers, replacement heart valves, implanted spinal cord stimulators

34
New cards

Device Types: Restricted

- Require prescriptions

- May restrict to patients who are trained

35
New cards

Device Types: Custom devices

Ordered to fit the needs of a patient

36
New cards

Device Types: Banned

- Banned from use in the US

- Prosthetic hair fibers

37
New cards

Adulteration

- Entire product or part is filthy, putrid, decomposed

- Prepared, packed, held under unsanitary conditions

- Methods used, facilities, and controls used for manufacture, processing, packaging, or holding do not conform to Current Good Manufacturing Practice (CGMP)

- Container is an issue (poisonous or deleterious)

- Contains unsafe coloring agent or is an unsafe coloring agent

- Claims to be official drug and strength, quality, purity different from the compendium standards

--- UNLESS plainly stated on the label (e.g. "Not USP")

- Not an official drug and the strength or purity falls below what is claimed

- Mixed or packed with a substance to reduce its quality or strength or complete substitution (entire drug or parts of it)

- A drug is considered adulterated, even if it is pure when:

--- Prepared, packaged, or held in conditions where it MAY have been contaminated

--- Exposed to a container that MAY have contaminated it

--- Manufactured under conditions that do not conform to CGMP

- Issues/potential issues with product itself

- Adulteration can occur in pharmacies

--- Improper storage

--- Mixed incorrectly

--- Counted without cleaning the tray

38
New cards

Current Good Drug Manufacturing Practice

- Set of regulations that establish minimum requirements for:

--- Methods, facilities, or controls used in the manufacture, packaging, or holding of a drug product

- Test small part of a batch for quality

- Applies to manufacturers

- Only applies to pharmacies if registered as an outsourcing facility or engage in activities deemed as manufacturers

- Manufacturers inspected by FDA every 2 years

39
New cards

Misbranding

- Drug that has false or misleading labeling

- Required information must be prominently displayed

--- Must be understandable by an ordinary individual under customary conditions or purchase and use

- Misleading container or limitations or sold under the name of another drug

- Dangerous to health when used in the dose, frequency, or duration described on label

- Packaging or labeling in violation of Poison Prevention Packaging Act

- Color additive for coloring only and not labeled as such

- Failure to comply with REMS

- Fails to bear product identifier (Rx-only)

- Drug comes from non-registered establishment

- Issues with the words associated with the product

- Prescription label requirements fall under misbranding

- Products can be adulterated AND misbranded

40
New cards

Adulteration VS. Misbranding

- Adulteration = something is wrong (or could be wrong) with the medication "INSIDE" the bottle

- Misbranding = issues with the "OUTSIDE" of the bottle/the label

41
New cards

Adulteration AND misbranding

- The capsules from this bottle of elderberry supplements were found to have contained no elderberry extract at all, but rather they were packed with bulking fillers.

- The capsules are adulterated because the supplement was substituted with another ingredient AND

- The capsules are misbranded because the capsules contain substances other than what was listed on the label

42
New cards

Pharmacist Adulteration Case in Indiana

- Compounding pharmacy in Indiana

- 2013-2016: 70 potency test failure notices

--- Medications under or over-potent

--- Drugs shipped to hospitals before receiving potency test results

--- Infants injected with over-potent morphine

43
New cards

United States v. Elmer

- 10-count indictment

--- 1 count of conspiracy to defraud the U.S.

--- 3 counts of distributing an adulterateddrug in interstate commerce

--- 6 counts of adulterating drugs while held for sale after shipment of a drug component in interstate commerce

44
New cards

Dietary Supplement Health and Education Act (DSHEA) 1994

- Manufacturers can make statements related to a structure or function of the body if the statement:

--- Claims product will benefit a classical nutrient deficiency (as long as prevalence of the disease in the US is disclosed as well)

--- Describes the role of dietary supplement in affecting the structure or function of the body

--- Characterizes the documented mechanism by which a nutrient or dietary supplement acts to maintain structure or function

--- Describes the general well-being from consumption of a nutrient or dietary ingredient

45
New cards

Dietary Supplements Requirements

- Manufacturers must have evidence for statements

--- Truthful, not misleading

- Label must contain "This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease"

- No premarket approval required

- Do not need to submit proof to FDA that product is safe or effective

46
New cards

DSHEA Concerns

- Marketing of unsafe dietary supplements occurs and FDA unable to act aggressively to protect the public

- Lack of consumer information about dietary supplements interacting with certain OTC and prescription medications

- Lack of quality standards; manufacturers not required to register

--- MUST comply with CGMP